Adamis Pharmaceuticals Stock (NASDAQ:ADMP)
Previous Close
$0.77
52W Range
$0.45 - $21.70
50D Avg
$0.90
200D Avg
$6.11
Market Cap
$7.25M
Avg Vol (3M)
$3.11M
Beta
1.28
Div Yield
-
ADMP Company Profile
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products for the treatment of asthma; and naloxone injection for the treatment of opioid overdose. It also offers APC400, a tempol gel use of reducing radiation dermatitis in patients undergoing treatment for cancer; and APC410 for the treatment of respiratory diseases, including asthma, respiratory syncytial virus, influenza, and COVID-19. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, and injectables; and veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California.
ADMP Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
| Product/Service | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|
| Compounded Pharmaceuticals | $13.75M | - | - |
| Sterile Product | $9.16M | - | - |
| Manufactured Product, Other | $2.78M | - | - |
| Non-Sterile Product | $4.59M | - | - |
| Outsourced Manufacturing | - | $3.76M | - |
| Non-Sterile | - | $4.86M | $5.97M |
| Sterile | - | $13.50M | $9.12M |
Fiscal year ends in Dec 22 | Currency in USD
Peer Comparison
| Ticker | Company |
|---|---|
| EVOK | Evoke Pharma, Inc. |
| TLRY | Tilray Brands, Inc. |
| AQST | Aquestive Therapeutics, Inc. |
| LFCR | Lifecore Biomedical, Inc. |
| ORGO | Organogenesis Holdings Inc. |
| GHSI | Guardion Health Sciences, Inc. |
| ALIM | Alimera Sciences, Inc. |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. |
| ACRX | Talphera, Inc. |
| LSDI | Lucy Scientific Discovery Inc. |
| CTLT | Catalent, Inc. |